BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/15/2024 9:49:53 AM | Browse: 527 | Download: 1475
Publication Name World Journal of Diabetes
Manuscript ID 87873
Country China
Received
2023-08-31 04:32
Peer-Review Started
2023-08-31 04:33
First Decision by Editorial Office Director
2023-12-25 07:18
Return for Revision
2023-12-25 07:18
Revised
2024-01-06 12:37
Publication Fee Transferred
Second Decision by Editor
2024-01-17 09:51
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2024-01-29 06:02
Articles in Press
2024-01-29 06:02
Edit the Manuscript by Language Editor
Typeset the Manuscript
2024-03-06 05:12
Publish the Manuscript Online
2024-03-15 09:49
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Urology & Nephrology
Manuscript Type Basic Study
Article Title MicroRNA-630 alleviates inflammatory reactions in rats with diabetic kidney disease by targeting toll-like receptor 4
Manuscript Source Unsolicited Manuscript
All Author List Qi-Shun Wu, Dan-Na Zheng, Cheng Ji, Hui Qian, Juan Jin and Qiang He
ORCID
Author(s) ORCID Number
Qi-Shun Wu http://orcid.org/0000-0003-4331-4280
Dan-Na Zheng http://orcid.org/0000-0001-6451-8585
Hui Qian http://orcid.org/0000-0002-0098-3196
Juan Jin http://orcid.org/0000-0003-2513-4665
Qiang He http://orcid.org/0000-0002-7460-649X
Funding Agency and Grant Number
Funding Agency Grant Number
Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China LHDMZ22H050001
Construction of Key Projects by Zhejiang Provincial Ministry WKJ-ZJ-2302
Zhejiang Province Chinese Medicine Modernization Program 2020ZX001
Key Project of Scientific Research Foundation of Chinese Medicine 2022ZZ002
“Pioneer” and “LeadingGoose” R&D Program of Zhejiang 2022C03118, 2023C03075
Key Project of Basic Scientific Research Operating Funds of Hangzhou Medical College KYZD202002
Corresponding Author Qiang He, MD, Chief Physician, Professor, Graduate School, Medical College of Soochow University, No. 1 Shizi Street, Gusu District, Suzhou 215006, Jiangsu Province, China. strong_he@163.com
Key Words Diabetic kidney disease; MicroRNA-630; Toll-like receptor 4; Mouse model; Renal tubular epithelial cells damage; Hyperglycemic model
Core Tip This study revealed that microRNA-630 (miR-630) expression in the renal tissue was significantly lower in diabetic kidney disease (DKD) rats than in normal rats. The miR-630 alleviates renal injury and inflammatory reactions in DKD rats by targeting toll-like receptor 4. Our findings provide new insights into the pathogenesis of DKD indicating that miR-630 may be a potential noninvasive biomarker for diagnosing and predicting the prognosis of DKD.
Publish Date 2024-03-15 09:49
Citation Wu QS, Zheng DN, Ji C, Qian H, Jin J, He Q. MicroRNA-630 alleviates inflammatory reactions in rats with diabetic kidney disease by targeting toll-like receptor 4. World J Diabetes 2024; 15(3): 488-501
URL https://www.wjgnet.com/1948-9358/full/v15/i3/488.htm
DOI https://dx.doi.org/10.4239/wjd.v15.i3.488
Full Article (PDF) WJD-15-488-with-cover.pdf
Full Article (Word) WJD-15-488.docx